ArticleThe Journal of supercritical fluids2022
Solubility of favipiravir (as an anti-COVID-19) in supercritical carbon dioxide: An experimental analysis and thermodynamic modeling.
Article in The Journal of supercritical fluids, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 59 citations in OpenAlex.
- Automated machine-learning framework for predicting drug solubility in supercritical COScientific reports · 2026Article
- Optimization algorithm for improving the prediction accuracy of API solubility in green solvent.Scientific reports · 2026Article
- Accelerating supercritical pharmaceutical formulation via interpretable data-driven prediction of drug solubility.Scientific reports · 2026Article
- Experimental investigation and thermodynamic correlation of chlordiazepoxide solubility in supercritical CO₂.Scientific reports · 2026Article
- Machine learning-assisted computation of the solubility of solid drugs in supercritical carbon dioxide.Frontiers in chemistry · 2026Article
- Integrating experimental data and machine learning models for solubility prediction of yellow 23 in supercritical carbon dioxide.RSC advances · 2025Article
- Investigation of Lacosamide solubility in supercritical carbon dioxide with machine learning models.Scientific reports · 2025Article
- Measurement and modeling of rizatriptan in supercritical COScientific reports · 2025Article
- Predicting drug solubility in supercritical carbon dioxide green solvent using machine learning models based on thermodynamic properties.Scientific reports · 2025Article
- Utilization of sequential model-based optimizer integrated machine learning models in correlation of famotidine solubility in supercritical carbon dioxide.Scientific reports · 2025Article
- Nilotinib hydrochloride monohydrate solubility in supercritical carbon dioxide + cosolvent: measurements and modeling.Scientific reports · 2025Article
- Enhancing methyldopa solubility via green supercritical fluid techniques using ethanol co-solvent.Scientific reports · 2025Article
- Thermodynamic analysis and intelligent modeling of statin drugs solubility in supercritical carbon dioxide.Scientific reports · 2025Article
- Computational intelligence modeling and optimization of small molecule API solubility in supercritical solvent for production of drug nanoparticles.Scientific reports · 2025Article
- Mesalazine solubility in supercritical carbon dioxide with and without cosolvent and modeling.Scientific reports · 2025Article
- Determination of the solubility of methyldopa in supercritical carbon dioxide for drug delivery applications: thermal analysis.Scientific reports · 2025Article
- Preparation, and ex vivo and in vivo Characterization of Favipiravir-Loaded Aspasomes and Niosomes for Nose-to-Brain Administration.International journal of nanomedicine · 2025Article
- Production of pazopanib hydrochloride nanoparticles (anti-kidney cancer drug) using a supercritical gas antisolvent (GAS) method.RSC advances · 2024Article
- Measuring and modeling the solubility of sulfasalazine in supercritical carbon dioxide to select methods for producing nanoparticles.Scientific reports · 2024Article
- Advancements in Antiviral Therapy: Favipiravir Sodium in Nasal Formulation.AAPS PharmSciTech · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Favipiravir is one of the most commonly prescribed drugs in the treatment of COVID-19 in the early stages of the disease. In this work, the solubility of favipiravir was measured in supercritical CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.